GlassScriptPhysician profile
James Tan Dunlap
NPI 1457577702
$6,371.04
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,830 · 2020: $2,272 · 2021: $230 · 2023: $40.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,112.01 | 2019-2020 | |
| Relievant Medsystems, INC. | $1,259.17 | 2019-2020 | |
| Globus Medical, INC. | $1,046.91 | 2019 | |
| Si-Bone, INC. | $272.00 | 2019-2020 | |
| Orthofix Medical, INC. | $175.96 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $131.51 | 2019 | |
| Centinel Spine, LLC | $83.72 | 2019-2020 | |
| Medtronic, INC. | $56.10 | 2021 | |
| Boston Scientific Corporation | $52.02 | 2020 | |
| Augmedics INC. | $40.19 | 2023 | Xvision |
| Sanofi-Aventis U.S. LLC | $24.91 | 2019 | |
| Stryker Corporation | $20.83 | 2019 | |
| Camber Spine Technologies LLC | $17.70 | 2019 | |
| Lilly USA, LLC | $16.92 | 2021 | |
| Titan Spine, LLC | $13.11 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $12.81 | 2019 | |
| Kci USA, INC. | $12.05 | 2020 | |
| Paratek Pharmaceuticals, INC. | $11.80 | 2019 | |
| Spineology INC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Dunlap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.